Brennan Michael J
Aeras, 1405 Research Blvd., Rockville, MD 20850, USA.
Iliad Biotechnologies, 230 East 15th Street, Suite 1-A, New York, NY 10003, USA.
Vaccines (Basel). 2017 Nov 10;5(4):43. doi: 10.3390/vaccines5040043.
This article is a Letter to the Editor. The major purpose of this Letter is to highlight the development of a new genetically altered whooping cough vaccine. Recently a baboon model has been used to show that this next generation pertussis vaccine can prevent colonization, as well as disease, and elicit antibodies against major pertussis antigens. Two phase I clinical trials have been performed, showing that this new vaccine is safe in humans, and a phase II trial will be performed in the US in 2018.
本文是一封致编辑的信。这封信的主要目的是强调一种新型基因改造百日咳疫苗的进展。最近,一种狒狒模型已被用于表明这种下一代百日咳疫苗可以预防定植以及疾病,并引发针对主要百日咳抗原的抗体。已经进行了两项I期临床试验,表明这种新疫苗在人体中是安全的,并且将于2018年在美国进行II期试验。